COVID-19 clinical trials to develop treatments will get answers faster if people collaborate, Susan Ellenberg, PhD, commented. “As some treatments show evidence of benefit, we will be moving to studies of drug combinations, and these trials will require larger sample sizes — meaning, in most cases, multicenter trials.”
To understand health and disease today, we need new thinking and novel science —the kind we create when multiple disciplines work together from the ground up. That is why this department has put forward a bold vision in population-health science: a single academic home for biostatistics, epidemiology and informatics.
© 2023 Trustees of the University of Pennsylvania. All rights reserved.. | Disclaimer
